دورية أكاديمية

Diagnostic Performance of Computed Tomography Coronary Angiography (from the Prospective National Multicenter Multivendor EVASCAN Study).

التفاصيل البيبلوغرافية
العنوان: Diagnostic Performance of Computed Tomography Coronary Angiography (from the Prospective National Multicenter Multivendor EVASCAN Study).
المؤلفون: Gueret, Pascal1 pascal.gueret@hmn.aphp.fr, Deux, Jean-François2, Bonello, Laurent3, Sarran, Anthony4, Tron, Christophe5, Christiaens, Luc6, Dacher, Jean-Nicolas7, Bertrand, David7, Leborgne, Laurent8, Renard, Cedric9, Caussin, Christophe10, Cluzel, Philippe11, Helft, Gerard12, Crochet, Dominique13, Vernhet-Kovacsik, Hélène14, Chabbert, Valérie15, Ferrari, Emile16, Gilard, Martine17, Willoteaux, Serge18, Furber, Alain19
المصدر: American Journal of Cardiology. 2013, Vol. 111 Issue 4, p471-478. 8p.
مصطلحات موضوعية: *TOMOGRAPHY, *CORONARY angiography, *CORONARY disease, *CORONARY arteries, *DATA analysis, *HEALTH outcome assessment
مستخلص: Computed tomographic coronary angiography (CTCA) has been proposed as a noninvasive test for significant coronary artery disease (CAD), but only limited data are available from prospective multicenter trials. The goal of this study was to establish the diagnostic accuracy of CTCA compared to coronary angiography (CA) in a large population of symptomatic patients with clinical indications for coronary imaging. This national, multicenter study was designed to prospectively evaluate stable patients able to undergo CTCA followed by conventional CA. Data from CTCA and CA were analyzed in a blinded fashion at central core laboratories. The main outcome was the evaluation of patient-, vessel-, and segment-based diagnostic performance of CTCA to detect or rule out significant CAD (≥50% luminal diameter reduction). Of 757 patients enrolled, 746 (mean age 61 ± 12 years, 71% men) were analyzed. They underwent CTCA followed by CA 1.7 ± 0.8 days later using a 64-detector scanner. The prevalence of significant CAD in native coronary vessels by CA was 54%. The rate of nonassessable segments by CTCA was 6%. In a patientbased analysis, sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios of CTCA were 91%, 50%, 68%, 83%, 1.82, and 0.18, respectively. The strongest predictors of false-negative results on CTCA were high estimated pretest probability of CAD (odds ratio [OR] 1.97, p <0.001), male gender (OR 1.5, p <0.002), diabetes (OR 1.5, p <0.0001), and age (OR 1.2, p <0.0001). In conclusion, in this large multicenter study, CTCA identified significant CAD with high sensitivity. However, in routine clinical practice, each patient should be individually evaluated, and the pretest probability of obstructive CAD should be taken into account when deciding which method, CTCA or CA, to use to diagnose its presence and severity. [ABSTRACT FROM AUTHOR]
قاعدة البيانات: Academic Search Index
الوصف
تدمد:00029149
DOI:10.1016/j.amjcard.2012.10.029